---
layout: post
title: "Assessing the Effects of Food on Drugs in Investigational New Drugs and New Drug Applications-Clinical Pharmacology Considerations; Guidance for Industry; Availability"
date: 2026-02-05 18:59:36 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-13520
original_published: 2022-06-24 00:00:00 +0000
significance: 8.00
---

# Assessing the Effects of Food on Drugs in Investigational New Drugs and New Drug Applications-Clinical Pharmacology Considerations; Guidance for Industry; Availability

**Published:** February 05, 2026 18:59 UTC
**Source:** Federal Register
**Original Published:** June 24, 2022 00:00 UTC
**Document Number:** 2022-13520

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Assessing the Effects of Food on Drugs in INDs and NDAs--Clinical Pharmacology Considerations." This guidance provides recommendations to sponsors planning to conduct food-effect (FE) studies for orally administered drug products as part of investigational new drug applications (INDs), new drug applications (NDAs), and supplements to these applications. This guidance finalizes the draft guidance of the same title issued on February 26, 2019.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/06/24/2022-13520/assessing-the-effects-of-food-on-drugs-in-investigational-new-drugs-and-new-drug)
- API: https://www.federalregister.gov/api/v1/documents/2022-13520

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
